Please join us for an enlightening session on BIORCHESTRA’s innovative IV-formulated and SC-formulated RNA therapeutics for neurodegenerative diseases such as Alzheimer’s Disease (AD), Amyotrophic Lateral Sclerosis (ALS), Parkinson’s Disease (PD), and other disorders such as retinal diseases and obesity. The presentation will be given by our VP & Chief Business Officer, David Oxley, at BIO USA.
- Speaker: David Oxley (CBO)
- Title: BIORCHESTRA’s Innovative IV-formulated and SC-formulated RNA therapeutics for neurodegenerative
- Date: June 6, 2024, at 10:00 a.m.
For more details and registration, visit: BIO USA Sessions
